Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Gunter RICHTER who wrote (537)	4/28/1999 12:21:00 AM
From: Mike McFarland	Read Replies (2) \| Respond to of 4474

The best thing these fellas can do for shareholders now is to just sell off the ARGENT platform--the transcription factor patents are gravy for the highest bidder. Merck could swallow the whole thing for 200M and that puts the stock around $10. Hoechst bought shares at $12 right? So, maybe I'm a tad low;-) That sort of desperation is echoed on the Yahoo thread...where silly estimates of anywhere between $6 to as high as $20 have been thrown out...all nonsense, and I'm full of crap as well. What will really happen is this thing will limp along for a few years. The science will continue to be praised and management cursed. {I personally don't have any opinion on either point...I have always said that my stocks are all darts...merely thrown at a sector which has been ignored...and therefore is cheap--The only thing I am qualified to do is buy shares...and lose my money--oh, and rant too much on these threads.} I sure would like to see that first scenario go through, uh, how about by May 18th? I think that is the magic day my warrants expire. Let's see... what was the only trade I made in the last few weeks? Uh, bought another 1000 Ariad shares?! Yup, I am a real glutton for punishment. I must have been dazzled by the science as I surfed around and discovered a few things. Unfortunately, after man learned to fly, the real money was made by Douglas and Boeing, not the Wright Brothers. Ten years from now some big pharma will be raking it in with signal transduction, controlling genes and transcription factors. The probability that the company will be named Ariad is probably low.